(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. David Wise discussing a phase 1 study of gotistobart (BNT316/ONC-392) in combination with ...

Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin-out of Scorpion Therapeutics, which sold its mutant-selective PI3Kα ...

BOSTON, June 10, 2025--Antares Therapeutics, Inc. ("Antares"), a biotechnology company developing first-in-class precision medicines for cancer and other serious diseases, launched today with $177 ...

Rogers (3-33) picked up Chris Wood for a golden duck in the final over but Hampshire reached 177-7 with Weatherley unbeaten on 63 off 47 balls.